U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07375901) titled 'the Blood-Aqeous Barrier During Anti-Angiogenic Therapy in Exudative Age-Related Macular Degeneration' on Jan. 22.
Brief Summary: To evaluate the status of the blood-aqueous barrier by objectively measuring protein concentration in the aqueous humor using laser flare photometry (LFP) in patients with exudative age-related macular degeneration (AMD) undergoing anti-angiogenic therapy.
Study Start Date: March 25, 2021
Study Type: INTERVENTIONAL
Condition:
AMD
Intervention:
DIAGNOSTIC_TEST: laser flare photometry before intravitreal injection
The first group was administered intravitreal injections of 2 mg (0.05 mL) aflibercept ...